Dataset Information


Effect of low-dose ketamine on post-operative serum IL-6 production among elective surgical patients: a randomized clinical trial.

ABSTRACT: BACKGROUND:Surgery and Anesthesia cause an excessive pro-inflammatory response. Mulago Hospital is faced with staff shortage making post-operative pain management difficult.Interleukin-6 (IL-6) drives inflammatory pain, endothelial cell dysfunction and fibrogenesis. Ketamine is cheap and, readily available. We hypothesized that its attenuation of serum IL-6 was a surrogate for clinical benefit. MATERIALS AND METHODS:Institutional Review Board's approval was sought and RCT was registered at clinical trials.gov (identifier number: NCT01339065). Consenting patients were randomized to receive pre-incision intravenous ketamine - 0.5mg/kg or 0.9% saline placebo in weighted dosing. Blood samples were collected and laboratory analyzed at baseline, post-operatively in PACU, 24 and 48 hours respectively. RESULTS:We recruited 39 patients of whom 18 were randomized to the ketamine arm and 21 in the placebo arm with follow up at 24 and 48 hours. Serum IL-6 and IL-1? levels were analyzed using ELIZA assay of pre-coated micro wells. Ketamine suppressed serum IL-6 at PACU with reduced increase at 24 hours. There was no reaction in 98% of IL-1? assayed. CONCLUSION:Low-dose ketamine attenuated early serum IL-6 levels due to surgical response with reduced 24 hour increase, but the difference was not statistically significant and we recommend more studies.


PROVIDER: S-EPMC5637036 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC4755104 | BioStudies
2008-01-01 | S-EPMC2504281 | BioStudies
2014-01-01 | S-EPMC4209651 | BioStudies
2013-01-01 | S-EPMC3992936 | BioStudies
2020-01-01 | S-EPMC7682613 | BioStudies
2016-01-01 | S-EPMC5580063 | BioStudies
1000-01-01 | S-EPMC3964324 | BioStudies
2017-01-01 | S-EPMC5530739 | BioStudies
2014-01-01 | S-EPMC4076328 | BioStudies
2018-01-01 | S-EPMC5846492 | BioStudies